Among the 60 BC cells with available data regarding ATP7B expression levels, ER-positive, PgR-positive, and HER2-positive cells had significantly higher ATP7B mRNA levels than their negative counterparts (p < 0.001, p = 0.002, and p = 0.040, respectively; Fig. 1b). Here, ATP7B is linked to breast cancer.